Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
GSK-101 by GSK for Solid Tumor: Likelihood of Approval
GSK-101 is under clinical development by GSK and currently in Phase II for Solid Tumor. According to GlobalData, Phase II...